Literature DB >> 16901452

Metronidazole: newly recognized cause of autonomic neuropathy.

Lisa D Hobson-Webb1, E Steve Roach, Peter D Donofrio.   

Abstract

Metronidazole is a commonly used antibiotic prescribed for the treatment of anaerobic and protozoal infections of the gastrointestinal and genitourinary tracts. It is associated with numerous neurologic complications, including peripheral neuropathy. Neuropathy is typically detected in patients on chronic therapy, although it has been documented in those taking large doses for acute infections. Numerous case reports have been published describing motor and sensory neuropathy, yet autonomic neuropathy has not been described with metronidazole use. A previously healthy 15-year-old girl presented with complaints of burning pain in her feet following a short course of metronidazole for vaginitis. She could obtain pain relief only by submerging her feet in ice water. Examination revealed cold and swollen lower extremities that became erythematous and very warm when removed from the ice water. Temperature perception was reduced to the upper third of the shin bilaterally. Deep tendon reflexes and strength were preserved. Nerve conduction studies demonstrated a peripheral neuropathy manifested by reduced sensory nerve and compound muscle action potentials. Reproducible sympathetic skin potential responses could not be obtained in the hand and foot, providing evidence of a concurrent autonomic neuropathy. A thorough evaluation revealed no other cause for her condition. Repeated nerve conduction studies and sympathetic skin potentials returned to normal over the course of 6 months, paralleling the patient's clinical improvement. Metronidazole is a potential cause of reversible autonomic neuropathy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16901452     DOI: 10.1177/08830738060210051201

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  13 in total

1.  Cases: Reversible cerebellar syndrome caused by metronidazole.

Authors:  Justyna R Sarna; A Keith W Brownell; Sarah Furtado
Journal:  CMAJ       Date:  2009-09-14       Impact factor: 8.262

2.  Metronidazole-induced central and peripheral nervous system toxicity.

Authors:  G Cação; S Fontes; M Salgado; T Rodrigues; Joana Damásio
Journal:  Neurol Sci       Date:  2015-05-20       Impact factor: 3.307

3.  Antibiotic-induced neurotoxicity.

Authors:  Shamik Bhattacharyya; Ryan Darby; Aaron L Berkowitz
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

4.  Acute Sensory and Autonomic Neuronopathy: A Devastating Disorder Affecting Sensory and Autonomic Ganglia.

Authors:  Joel Gutierrez; Jose-Alberto Palma; Horacio Kaufmann
Journal:  Semin Neurol       Date:  2020-09-09       Impact factor: 3.420

Review 5.  Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components.

Authors:  Alison E Barnhill; Matt T Brewer; Steve A Carlson
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

Review 6.  Neurotoxic effects associated with antibiotic use: management considerations.

Authors:  Marie F Grill; Rama K Maganti
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

7.  Metronidazole-induced encephalopathy in a patient with infectious colitis: a case report.

Authors:  Hoon Kim; Young Woo Kim; Seoung Rim Kim; Ik Seong Park; Kwang Wook Jo
Journal:  J Med Case Rep       Date:  2011-02-14

8.  Nonantibiotic Effects of Fluoroquinolones in Mammalian Cells.

Authors:  Sujan Badal; Yeng F Her; L James Maher
Journal:  J Biol Chem       Date:  2015-07-23       Impact factor: 5.157

9.  Peripheral neuropathy from use of linezolid and metronidazole in a pediatric patient.

Authors:  Athena McConnell; Krista Baerg
Journal:  IDCases       Date:  2021-06-29

Review 10.  Drug-Induced Peripheral Neuropathy: A Narrative Review.

Authors:  Mark R Jones; Ivan Urits; John Wolf; Devin Corrigan; Luc Colburn; Emily Peterson; Amber Williamson; Omar Viswanath
Journal:  Curr Clin Pharmacol       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.